Burning mouth syndrome associated with tumor necrosis factor (TNF)-α inhibitor

Int J Dermatol. 2020 Mar;59(3):e70-e71. doi: 10.1111/ijd.14681. Epub 2019 Oct 24.

Authors

Alessio Gambardella¹, Gaetano Licata¹, Alina De Rosa¹, Marina Agozzino¹, Caterina Mariarosaria Giorgio¹, Roberto Alfano², Giuseppe Argenziano¹

Affiliations

¹ Dermatology Unit, Department of Mentals and Physical Health and Preventive medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
² Department of Anesthesiology, Surgery and Emergency, University of Campania Luigi Vanvitelli, Naples, Italy.

PMID: 31646631
DOI: 10.1111/ijd.14681

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
Burning Mouth Syndrome / chemically induced*
Burning Mouth Syndrome / diagnosis
Burning Mouth Syndrome / immunology
Etanercept / adverse effects*
Female
Humans
Middle Aged
Psoriasis / diagnosis
Psoriasis / drug therapy*
Psoriasis / immunology
Severity of Illness Index
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Tumor Necrosis Factor-alpha / immunology

Substances

Anti-Inflammatory Agents, Non-Steroidal
TNF protein, human
Tumor Necrosis Factor-alpha
Etanercept